KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Ginkgo Bioworks Holdings (DNA) Invested Capital (2019 - 2025)

Ginkgo Bioworks Holdings (DNA) has disclosed Invested Capital for 5 consecutive years, with $1.3 billion as the latest value for Q3 2023.

  • For the quarter ending Q3 2023, Invested Capital fell 13.24% year-over-year to $1.3 billion, compared with a TTM value of $1.3 billion through Sep 2023, down 13.24%, and an annual FY2022 reading of $1.7 billion, up 10.95% over the prior year.
  • Invested Capital was $1.3 billion for Q3 2023 at Ginkgo Bioworks Holdings, down from $1.5 billion in the prior quarter.
  • Across five years, Invested Capital topped out at $1.7 billion in Q4 2022 and bottomed at $356.4 million in Q2 2021.
  • Average Invested Capital over 5 years is $1.2 billion, with a median of $1.5 billion recorded in 2022.
  • The sharpest move saw Invested Capital surged 341.13% in 2022, then fell 13.24% in 2023.
  • Year by year, Invested Capital stood at $501.9 million in 2019, then dropped by 6.31% to $470.2 million in 2020, then soared by 233.34% to $1.6 billion in 2021, then increased by 10.95% to $1.7 billion in 2022, then dropped by 27.97% to $1.3 billion in 2023.
  • Business Quant data shows Invested Capital for DNA at $1.3 billion in Q3 2023, $1.5 billion in Q2 2023, and $1.6 billion in Q1 2023.